We are live on ! Find out more
CAPR icon

Capricor Therapeutics
CAPR

19 hedge funds and large institutions have $3.25M invested in Capricor Therapeutics in 2018 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

1% more capital invested

Capital invested by funds: $3.23M → $3.25M (+$20K)

0.02% less ownership

Funds ownership: 0.86% → 0.83% (-0.02%)

5% less funds holding

Funds holding: 20 → 19 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
6
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
Vanguard Group
Pennsylvania
+$103K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$56.7K
3
BlackRock
BlackRock
New York
+$53.6K
4
Northern Trust
Northern Trust
Illinois
+$9.88K
5
VF
Virtu Financial
New York
+$5.92K

Top Sellers

1
BAM
Belpointe Asset Management
Nevada
-$98K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$66.4K
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$2.26K
Name Holding Trade Value Shares
Change 		Change in
Stake
Brown Advisory
1
Brown Advisory
Maryland
$1.52M – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.06M +$103K +7,546 +11%
CBA
3
Coastal Bridge Advisors
Connecticut
$160K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$159K +$56.7K +4,169 +54%
VF
5
Virtu Financial
New York
$76K +$5.92K +435 +8%
AA
6
Apriem Advisors
California
$67K – – –
Northern Trust
7
Northern Trust
Illinois
$62K +$9.88K +726 +19%
BlackRock
8
BlackRock
New York
$59K +$53.6K +3,938 +956%
Bank of New York Mellon
9
Bank of New York Mellon
New York
$34K -$2.26K -166 -6%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$16K -$66.4K -4,880 -80%
HIIFS
11
Harel Insurance Investments & Financial Services
Israel
$9K – – –
Bank of America
12
Bank of America
North Carolina
$7K – – –
PA
13
Perceptive Advisors
New York
$5K – – –
CFN
14
Cordasco Financial Network
Florida
$4K – – –
LTFS
15
Ladenburg Thalmann Financial Services
Florida
$4K – – –
FANJ
16
Financial Architects (New Jersey)
New Jersey
$3K – – –
AG
17
Advisor Group
Arizona
$3K +$2.72K +200 New
UBS Group
18
UBS Group
Switzerland
$2K +$1.17K +86 +215%
BAM
19
Belpointe Asset Management
Nevada
– -$98K -7,229 Closed

CAPR Hedge Fund Activity: Q2 2018 in Review

19 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Capricor Therapeutics (CAPR) for Q2 2018, worth a combined $3.25M — up 0.62% from $3.23M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of CAPR and 1 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 6 added.

The largest buyer was Vanguard Group, adding an estimated $103K. The largest seller was Belpointe Asset Management, exiting entirely with an estimated $98K sold.

  • 19 institutional investors held Capricor Therapeutics (CAPR) as of Q2 2018, down from 20 in Q1 2018.
  • Funds reported $3.25M of Capricor Therapeutics stock for Q2 2018, up 0.62% quarter-over-quarter.
  • 1 fund opened new Capricor Therapeutics positions in Q2 2018 and 2 closed out, a net change of -1 holder.
  • The largest Capricor Therapeutics buyer in Q2 2018 was Vanguard Group, an estimated $103K added.
  • The largest Capricor Therapeutics seller in Q2 2018 was Belpointe Asset Management, an estimated $98K sold.

Based on aggregated 13F filings for Q2 2018.